Cargando…

Proposal for a more practical classification of antineutrophil cytoplasmic antibody-associated vasculitis

The nomenclature for antineutrophil cytoplasmic antibody (ANCA)-associated kidney disease has evolved from honorific eponyms to a descriptive-based classification scheme (Chapel Hill Consensus Conference 2012). Microscopic polyangiitis, granulomatosis with polyangiitis and eosinophilic granulomatosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliva-Damaso, Nestor, Bomback, Andrew S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	CKJ Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247737/ https://www.ncbi.nlm.nih.gov/pubmed/34221368 http://dx.doi.org/10.1093/ckj/sfaa255

Ejemplares similares

Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease
por: Oliva-Damaso, Nestor, et al.
Publicado: (2022)

Intravenous Methylprednisolone in Induction Therapy for ANCA-Associated Vasculitis: How Low Can We Go?
por: Oliva-Damaso, Nestor, et al.
Publicado: (2023)

Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Geetha, Duvuru, et al.
Publicado: (2018)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review
por: Choi, Chan-Bum, et al.
Publicado: (2019)

Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Netherlands
por: Dirikgil, Ebru, et al.
Publicado: (2021)

Evaluation of the Oxford classification in immunoglobulin A vasculitis with nephritis: a cohort study and meta-analysis
por: Yu, Bingxin, et al.
Publicado: (2020)

Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
por: Pyo, Jung Yoon, et al.
Publicado: (2023)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015)

Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017)

The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
por: Koukoulaki, Maria, et al.
Publicado: (2019)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
por: Li, Weiran, et al.
Publicado: (2021)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
por: Kim, Yoon Kook, et al.
Publicado: (2021)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
por: Moog, Philipp, et al.
Publicado: (2015)

Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
por: Arman, Farid, et al.
Publicado: (2018)

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Merkel, Peter A., et al.
Publicado: (2020)

Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines
por: Ahn, Sung Soo, et al.
Publicado: (2023)

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019)

Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Ohashi, Keiji, et al.
Publicado: (2017)

Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Tanaka, Rika, et al.
Publicado: (2018)

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndrome
por: Aeddula, Narothama Reddy, et al.
Publicado: (2018)

Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Morishita, Michiko, et al.
Publicado: (2017)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
por: Felzer, Jamie R., et al.
Publicado: (2021)

Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis
por: Casal Moura, Marta, et al.
Publicado: (2021)

Challenges of defining renal response in ANCA-associated vasculitis: call to action?
por: Odler, Balazs, et al.
Publicado: (2023)

Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitis
por: Cao, Binxin, et al.
Publicado: (2023)

Acute Respiratory Failure as Primary Manifestation of Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis
por: Sourla, Evdokia, et al.
Publicado: (2014)

Caveolin-1 Single Nucleotide Polymorphism in Antineutrophil Cytoplasmic Antibody Associated Vasculitis
por: Chand, Sourabh, et al.
Publicado: (2013)

HLA-B52-positive Aortitis with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Karino, Kohei, et al.
Publicado: (2016)

Aortic Aneurysm as a Complication of Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Satomura, Atsushi, et al.
Publicado: (2017)

Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis
por: Morishita, Michiko, et al.
Publicado: (2019)

Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis
por: Fukui, Shoichi, et al.
Publicado: (2020)

Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody‐associated vasculitis
por: Lee, Lucy Eunju, et al.
Publicado: (2021)

Predictors of Mortality in Critically Ill Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Zhang, Yuqi, et al.
Publicado: (2021)

Tofacitinib-Induced Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis With Crescentic Glomerulonephritis
por: Asemota, Uyioghosa, et al.
Publicado: (2021)

Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: van Leeuwen, Jolijn R., et al.
Publicado: (2021)

Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2020)

Clinical features of Korean elderly patients with antineutrophil cytoplasmic antibody-associated vasculitis
por: Yoo, Byung-Woo, et al.
Publicado: (2021)

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement
por: Wong, Albert Hing, et al.
Publicado: (2022)

Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
por: Pyo, Jung Yoon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_asg8pkqra3erpfgei8jfg9qkn0